SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Suven Life Sciences gets two product patents

21 Jun 2011 Evaluate

Suven Life Sciences has received two product patents, one from Europe and the other from New Zealand. These grants were received for the New Chemical Entities (NCE) for the treatment of neurodegenerative disease. These patents are valid till 2027 and 2025. With the two new patents, Suven now has a total of ten granted patents in Europe and 11 in New Zealand.crackcrack

Suven Life Sciences Share Price

220.35 -3.80 (-1.70%)
11-May-2026 09:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1845.75
Dr. Reddys Lab 1275.50
Cipla 1333.75
Zydus Lifesciences 934.50
Lupin 2243.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×